Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| ARGX | ARGENX SE | $35.11B | 60,760,957 | 54.89% | 0.00% | ||||
| CRMD | CORMEDIX INC | $987.53M | 67,824,659 | 34.63% | 9.81% | Net Selling | Net Buying | ||
| GYRE | GYRE THERAPEUTICS INC | $749.12M | 93,757,602 | 1.58% | 98.42% | Net Buying | Net Buying | ||
| TGTX | TG THERAPEUTICS INC | $5.72B | 158,755,036 | 55.61% | 44.39% | Net Selling | |||
| CORT | CORCEPT THERAPEUTICS INC | $7.43B | 106,044,696 | 29.74% | 70.26% | Net Buying | Net Selling | ||
| RPRX | ROYALTY PHARMA PLC | $19.59B | 562,240,269 | 54.13% | 17.86% | Net Buying | Net Buying | ||
| VCEL | VERICEL CORP | $2.15B | 50,342,969 | 91.20% | 8.80% | Net Selling | Net Buying | ||
| KRYS | KRYSTAL BIOTECH INC | $3.96B | 28,898,680 | 78.32% | 21.68% | Net Selling | |||
| AUPH | AURINIA PHARMACEUTICALS INC | $1.11B | 135,104,302 | 45.82% | 11.36% | Net Buying | |||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.89B | 57,424,319 | 70.06% | 29.94% | Net Selling | Net Selling | ||
| HALO | HALOZYME THERAPEUTICS INC | $6.65B | 123,221,000 | 77.78% | 22.22% | Net Selling | Net Selling | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $2.87B | 121,975,152 | 79.95% | 15.82% | Net Selling | Net Selling | ||
| INCY | INCYTE CORP | $13.11B | 193,569,934 | 76.66% | 23.34% | Net Selling | Net Selling | ||
| ADMA | ADMA BIOLOGICS INC | $4.97B | 238,734,246 | 78.46% | 21.54% | Net Selling | Net Selling | ||
| MNKD | MANNKIND CORP | $1.13B | 303,932,852 | 35.95% | 64.05% | Net Selling | Net Selling | ||
| EXEL | EXELIXIS INC | $11.34B | 272,708,280 | 91.77% | 5.25% | Net Selling | Net Selling | ||
| NVO | NOVO NORDISK A S | $356.44B | 4,465,000,000 | 7.25% | 0.00% | ||||
| MDXG | MIMEDX GROUP INC | $892.12M | 147,702,140 | 45.75% | 54.25% | Net Selling | Net Buying | ||
| TECH | BIO-TECHNE CORP | $7.92B | 156,767,295 | 97.67% | 2.33% | Net Buying | Net Buying | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $6.69B | 61,632,841 | 27.82% | 72.18% | Net Selling | Net Buying | ||
| VCYT | VERACYTE INC | $2.07B | 78,314,611 | 66.47% | 33.53% | Net Selling | Net Selling | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $10.78B | 191,775,665 | 94.96% | 1.74% | Net Selling | Net Selling | ||
| NAGE | NIAGEN BIOSCIENCE INC | $1.07B | 78,769,662 | 15.04% | 84.96% | Net Buying | Net Buying | ||
| GMAB | GENMAB A | $15.11B | 66,197,244 | 98.03% | 0.00% | ||||
| ACAD | ACADIA PHARMACEUTICALS INC | $3.63B | 167,361,851 | 72.62% | 27.38% | Net Selling | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.